My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

REGENXBIO Inc. - Common Stock (NQ:RGNX)

7.990 -0.360 (-4.31%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about REGENXBIO Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Progress Software Posts Strong Q4 Results, Joins Impinj, REGENXBIO And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session ↗

January 17, 2024

U.S. stock futures were lower this morning, with the Dow Jones futures falling more than 100 points on Wednesday. Shares of Progress Software Corporation (NASDAQ: PRGS) rose in pre-market trading as...

Via Benzinga

Topics Stocks

Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 08, 2024

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on...

Via Benzinga

Earnings Preview For Regenxbio ↗

November 07, 2023

Via Benzinga

What 4 Analyst Ratings Have To Say About Regenxbio ↗

October 04, 2023

Via Benzinga

The Latest Analyst Ratings for Regenxbio ↗

August 29, 2023

Via Benzinga

Earnings Preview: Regenxbio ↗

August 01, 2023

Via Benzinga

Boeing, Pacific Biosciences of California And Other Big Stocks Moving Lower On Monday ↗

January 08, 2024

U.S. stocks traded mixed, with the Dow Jones index falling around 80 points on Monday. Shares of The Boeing Company (NYSE: BA) fell during Friday’s session after an exit door blew out of a 737 aircraft...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 30, 2023

Via Benzinga

RegenXbio's Potential Blockbuster: Analyst is Bullish On Stock Citing Potential Gains From AAV Gene Therapies Resurgence ↗

June 20, 2023

Baird has initiated coverage on RegenXbio Inc (NASDAQ: RGNX) with an Outperform rating and a

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 2, 2023 ↗

June 02, 2023

Via Benzinga

Regenxbio's Return On Capital Employed Insights ↗

May 11, 2023

Via Benzinga

Analyst Expectations for Regenxbio's Future ↗

May 09, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

October 05, 2023

On Thursday, 369 companies hit new 52-week lows.

Via Benzinga

What 6 Analyst Ratings Have To Say About Regenxbio ↗

July 12, 2023

Via Benzinga

5 Analysts Have This to Say About Regenxbio ↗

June 20, 2023

Via Benzinga

The Latest Analyst Ratings for Regenxbio ↗

June 02, 2023

Via Benzinga

Earnings Preview: Regenxbio ↗

February 27, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

September 11, 2023

Monday's session saw 175 companies set new 52-week lows.

Via Benzinga

Does an FDA Fast Track Designation Make Regenxbio Stock a Buy Now? ↗

April 15, 2023

The company focuses on using its technology for gene-editing therapies.

Via The Motley Fool

Tesla To Rally Over 16%? Here Are 10 Other Analyst Forecasts For Monday ↗

March 06, 2023

Citigroup raised the price target for The Manitowoc Company, Inc. (NYSE: MTW) from $11 to $21. Citigroup analyst Timothy Thein maintained a Neutral rating. Manitowoc shares fell 2.4% to $19.09 in...

Via Benzinga

Looking Into Regenxbio's Return On Capital Employed ↗

November 22, 2022

Via Benzinga

5 Analysts Have This to Say About Regenxbio ↗

November 21, 2022

Via Benzinga

What 5 Analyst Ratings Have To Say About Regenxbio ↗

November 04, 2022

Within the last quarter, Regenxbio (NASDAQ:RGNX) has observed the following analyst ratings:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 20, 2023 ↗

June 20, 2023

Via Benzinga

3D Systems, CarGurus, Sarepta Therapeutics And Other Big Stocks Moving Higher On Wednesday ↗

March 01, 2023

U.S. stocks traded lower, with the Dow Jones dropping around 80 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Regenxbio Says Diabetic Retinopathy Gene Therapy Shows Meaningful Improvements In Disease Severity ↗

November 03, 2022

Via Benzinga

Recap: Regenxbio Q3 Earnings ↗

November 03, 2022

Regenxbio (NASDAQ:RGNX) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:05 AM. Here's what investors need to know about the announcement.

Via Benzinga

Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

May 16, 2023

Gainers GD Culture Group Limited (NASDAQ: GDC) shares climbed 121.9% to $9.63 after gaining over 8% on Monday. GD Culture recently announced an $11.55 million registered direct offering.

Via Benzinga

Earnings Scheduled For February 28, 2023 ↗

February 28, 2023

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter.

Via Benzinga

One in Five Americans Who Have Been Infected With the Virus Said to Have Long COVID

November 17, 2022

Palm Beach, FL – November 17, 2022 – FinancialNewsMedia.com News Commentary – Since the beginning of the pandemic, the critical effort of researchers is to understand how coronavirus damages the body....

Via FinancialNewsMedia

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.